TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds May 27, 2005
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive In Brief: William Roper To Head Health Research Center; Announcement Of New NIH director Is Imminent July 2, 1993